Update on C3 glomerulopathy: a complement-mediated disease

F Caravaca-Fontán, L Lucientes, T Cavero, M Praga - Nephron, 2020 - karger.com
Abstract C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of
the alternative complement pathway in plasma and the glomerular microenvironment. The …
被引用次数：63 相关文章

Update on C3 Glomerulopathy: A Complement-Mediated Disease

F Caravaca-Fontán, L Lucientes, T Cavero… - …, 2020 - pubmed.ncbi.nlm.nih.gov
C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of the
alternative complement pathway in plasma and the glomerular microenvironment. The …
[PDF] researchgate.net

[PDF][PDF] Update on C3 Glomerulopathy: A Complement-Mediated Disease

F Caravaca-Fontána, L Lucientesa, T Caverod… - Nephron, 2020 - researchgate.net
Abstract C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of
the alternative complement pathway in plasma and the glomerular microenvironment. The …

Update on C3 Glomerulopathy: A Complement-Mediated Disease.

F Caravaca-Fontán, L Lucientes, T Cavero, M Praga - Nephron, 2020 - europepmc.org
C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of the
alternative complement pathway in plasma and the glomerular microenvironment. The …
[PDF] archive.org

[PDF][PDF] Update on C3 Glomerulopathy: A Complement-Mediated Disease

F Caravaca-Fontána, L Lucientesa, T Caverod… - Nephron, 2020 - scholar.archive.org
Abstract C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of
the alternative complement pathway in plasma and the glomerular microenvironment. The …

Update on C3 Glomerulopathy: A Complement-Mediated Disease

F Caravaca-Fontán, L Lucientes, T Cavero, M Praga - Nephron, 2020 - karger.com
Abstract C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of
the alternative complement pathway in plasma and the glomerular microenvironment. The …
[PDF] academia.edu

[PDF][PDF] Update on C3 Glomerulopathy: A Complement-Mediated Disease

F Caravaca-Fontána, L Lucientesa, T Caverod… - Nephron, 2020 - academia.edu
Abstract C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of
the alternative complement pathway in plasma and the glomerular microenvironment. The …

Update on C3 Glomerulopathy: A Complement-Mediated Disease

F Caravaca-Fontán, L Lucientes, T Cavero, M Praga - Nephron, 2020 - cir.nii.ac.jp
抄録< jats: p> C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to
dysregulation of the alternative complement pathway in plasma and the glomerular …